Dräger receives Innovative Technology Designation from Vizient for Atlan® A350/ A350XL Anesthesia Machines
Dräger has received an Innovative Technology Product designation from Vizient for its Atlan® A350/A350XL Anesthesia Machines. The designation, awarded by Vizient (the largest healthcare performance improvement company in the US), recognizes products that enhance clinical care, patient safety, and healthcare operations.
The Atlan family of anesthesia workstations features an electronic piston ventilator for precise ventilation across all patient ages, extensive safety features, and optimization for low-flow anesthesia. The system includes a Low Flow Wizard tool and recycling of sampled breathing gas, reducing anesthetic agent consumption and environmental impact.
Dräger, which generated revenues of €3.4 billion in 2023 and operates in over 190 countries, is a Vizient Pediatric Program supplier in four categories: Anesthesia Machines, Infant Care and Phototherapy, Ventilators, and OR Lights, Columns, and Booms.
Dräger ha ricevuto la designazione di Prodotto Innovativo Tecnologico da Vizient per le sue Macchine Anestesiologiche Atlan® A350/A350XL. Questa designazione, conferita da Vizient (la più grande azienda di miglioramento delle prestazioni sanitarie negli Stati Uniti), riconosce i prodotti che migliorano le cure cliniche, la sicurezza del paziente e le operazioni sanitarie.
La famiglia di stazioni di lavoro per anestesia Atlan presenta un ventilatore a pistone elettronico per una ventilazione precisa in tutte le fasce di età dei pazienti, ampie caratteristiche di sicurezza e ottimizzazione per anestesia a basso flusso. Il sistema include uno strumento Low Flow Wizard e il riciclo del gas respiratorio campionato, riducendo il consumo di agenti anestetici e l'impatto ambientale.
Dräger, che ha generato ricavi di 3,4 miliardi di euro nel 2023 e opera in oltre 190 paesi, è fornitore del Programma Pediatrico Vizient in quattro categorie: Macchine Anestesiologiche, Cura dei Neonati e Fototerapia, Ventilatori, e Luci da Operazione, Colonne e Bracci.
Dräger ha recibido la designación de Producto Tecnológico Innovador de Vizient para sus Máquinas de Anestesia Atlan® A350/A350XL. Esta designación, otorgada por Vizient (la mayor empresa de mejora del rendimiento en el sector salud en EE.UU.), reconoce productos que mejoran la atención clínica, la seguridad del paciente y las operaciones en salud.
La familia de estaciones de trabajo de anestesia Atlan cuenta con un ventilador de pistón electrónico para una ventilación precisa en todas las edades de los pacientes, amplias características de seguridad y optimización para anestesia de bajo flujo. El sistema incluye una herramienta Low Flow Wizard y el reciclaje del gas respiratorio muestreado, reduciendo el consumo de agentes anestésicos y el impacto ambiental.
Dräger, que generó ingresos de 3,4 mil millones de euros en 2023 y opera en más de 190 países, es proveedor del Programa Pediátrico de Vizient en cuatro categorías: Máquinas de Anestesia, Cuidado de Recién Nacidos y Fototerapia, Ventiladores y Luces de Quirófano, Columnas y Brazo.
Dräger는 Vizient로부터 Atlan® A350/A350XL 마취 기계에 대해 혁신 기술 제품 지정서를 받았습니다. 이 지정서는 미국에서 가장 큰 의료 성과 개선 회사인 Vizient에서 수여하며, 임상 치료, 환자 안전 및 의료 운영을 향상시키는 제품을 인정합니다.
Atlan 마취 작업站 가족은 모든 연령대의 환자에 대해 정밀한 환기 기능을 제공하는 전자 피스톤 환기기를 특징으로 하며, 광범위한 안전 기능과 저유량 마취를 위한 최적화를 제공합니다. 이 시스템은 Low Flow Wizard 도구와 샘플링된 호흡 가스를 재활용하는 기능을 포함하여, 마취제 소비와 환경 영향을 줄입니다.
Dräger는 2023년에 34억 유로의 수익을 올렸으며 190개국 이상에서 운영되고 있는 회사로, 네 가지 범주에서 Vizient의 소아 프로그램 공급업체입니다: 마취 기계, 신생아 관리 및 광선 요법, 환기 장치, 수술용 조명 및 기둥과 붐.
Dräger a reçu la désignation de Produit Technologique Innovant de Vizient pour ses Machines d'Anesthésie Atlan® A350/A350XL. Cette désignation, attribuée par Vizient (la plus grande entreprise d'amélioration des performances des soins de santé aux États-Unis), reconnaît les produits qui améliorent les soins cliniques, la sécurité des patients et les opérations de santé.
La famille des stations de travail d'anesthésie Atlan est dotée d'un ventilateur à piston électronique pour une ventilation précise pour tous les âges des patients, de fonctionnalités de sécurité étendues et d'une optimisation pour l'anesthésie à faible débit. Le système comprend un outil Low Flow Wizard et le recyclage du gaz respiratoire échantillonné, réduisant ainsi la consommation d'agents anesthésiques et l'impact environnemental.
Dräger, qui a généré des revenus de 3,4 milliards d'euros en 2023 et opère dans plus de 190 pays, est un fournisseur du Programme Pédiatrique de Vizient dans quatre catégories : Machines d'Anesthésie, Soins des Nourrissons et Photothérapie, Ventilateurs, et Éclairages de Salle d'Opération, Colonnes et Bras.
Dräger hat von Vizient die Auszeichnung als Innovatives Technologieprodukt für seine Anästhesiemaschinen Atlan® A350/A350XL erhalten. Diese Auszeichnung, die von Vizient (dem größten Unternehmen zur Verbesserung der Gesundheitsleistung in den USA) verliehen wird, erkennt Produkte an, die die klinische Versorgung, die Patientensicherheit und die Gesundheitsbetriebe verbessern.
Die Atlan-Familie von Anästhesiearbeitsplätzen verfügt über einen elektronischen Kolbenventilator für präzise Belüftung bei allen Patientenalter, umfangreiche Sicherheitsmerkmale und eine Optimierung für Niedrigflussanästhesie. Das System umfasst ein Low Flow Wizard-Tool und die Wiederverwertung von entnommenem Atemgas, wodurch der Verbrauch von Anästhetika und die Umweltbelastung reduziert werden.
Dräger, das 2023 einen Umsatz von 3,4 Milliarden Euro erzielt hat und in über 190 Ländern tätig ist, ist Lieferant des Vizient-Pädiatrieprogramms in vier Kategorien: Anästhesiemaschinen, Neugeborenenpflege und Phototherapie, Beatmungsgeräte sowie OP-Leuchten, Säulen und Arms.
- Received Innovative Technology Product designation from largest US healthcare improvement company
- Product features enhance both clinical efficiency and environmental sustainability
- Company has strong market presence with €3.4 billion revenue in 2023
- Supplier status in multiple categories with major healthcare improvement company
- None.
Designation recognizes Vizient-contracted products that bring improvements to the healthcare industry
Each year, healthcare experts serving on Vizient member-led councils review select products and technologies for their potential to enhance clinical care, patient safety, healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to previously contracted products to signal healthcare providers the impact of these innovations on patient care and business models of healthcare organizations.
Anesthesia workstations designed to make a clinical, financial, operational, and environmental impact
Dräger's Atlan family of anesthesia workstations exemplifies the company's commitment to critical care excellence and sustainable healthcare practices. Designed to enhance patient safety and operational efficiency in operating rooms, the Atlan is equipped with a robust electronic piston ventilator, ensuring precise ventilation for patients ranging from neonates to adults. Its extensive safety features help prevent unintentional high tidal volumes and inspiratory pressures, supporting clinicians in delivering optimal care.
Optimized for low- and minimal-flow anesthesia, the Atlan aims to reduce anesthetic agent consumption and environmental impact. The Low Flow Wizard tool standardizes delivery practices, while the system recycles sampled breathing gas back into the breathing system, minimizing waste. An actively warmed breathing system helps prevent condensation in low-flow conditions, further enhancing efficiency.
Incorporating sustainable green anesthesia practices, the design of the Atlan not only reduces anesthetic agent usage but also lowers the environmental footprint of surgical procedures. By combining advanced technology with eco-friendly features, Dräger continues its commitment to innovation and environmental responsibility in healthcare.
"Dräger is committed to shaping the future of healthcare with technology that serves both people and the planet," said David Karchner, Senior Director of Marketing, Operating Room, Monitoring, and Government Solutions at Draeger, Inc. "The Atlan family is more than just an anesthesia workstation — it's a statement of our commitment to critical care and sustainable healthcare practices. Our goal with the Atlan introduction was to provide our healthcare partners the tools to improve their clinical, financial, operational efficiency, while also supporting their sustainability efforts. Receiving the Innovative Technology Designation from Vizient validates that we're on the right track."
Dräger is a Vizient Pediatric Program supplier in four categories: Anesthesia Machines, Infant Care and Phototherapy, Ventilators, and OR Lights, Columns, and Booms.
"What makes a product worthy of this designation is that it has a unique quality that differentiates it from its competitors," said Kelly Flaharty, senior director contract services and Vizient Innovative Technology Program leader. "Our provider customer council determined that Dräger met this standard and recognizes its potential to improve quality outcomes."
Vizient, Inc.
Vizient represents a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute healthcare providers and represents approximately
You can find more information and pictures in our press center:
https://www.draeger.com/en-us_us/Newsroom/Press-Center
Disclaimer
Dräger is an international leader in the fields of medical and safety technology. Our products protect, support, and save lives. Founded in 1889, Dräger generated revenues of around
Contact |
View original content to download multimedia:https://www.prnewswire.com/news-releases/drager-receives-innovative-technology-designation-from-vizient-for-atlan-a350-a350xl-anesthesia-machines-302362412.html
SOURCE Draeger
FAQ
What is the significance of Vizient's Innovative Technology designation for Dräger's Atlan anesthesia machines?
How does the Atlan A350/A350XL anesthesia machine contribute to environmental sustainability?
What are the key clinical features of Dräger's Atlan anesthesia workstations?
What was Dräger's revenue in 2023 and global presence?